Trials / Completed
CompletedNCT05606120
H-35 CL TRAUMA Cemented Femoral Stem
A Post-market Study Evaluating Clinical and Radiographic Early Outcomes of Hip Arthroplasty With CL TRAUMA Cemented Femoral Stem
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 54 (actual)
- Sponsor
- Limacorporate S.p.a · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Study design: monocentric, retrospective, observational and post-market clinical study. Purpose: To demonstrate the safety and performance of CL TRAUMA femoral stem. The eligible study population is represented by the entire population that underwent a hip replacement with CL TRAUMA femoral stem from 2017 to 2023 at Azienda Ospedaliera di Padova (IT) in accordance with the indication for use of the product.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CL TRAUMA femoral stem | Hip arthroplasty according to the instruction for use. |
Timeline
- Start date
- 2022-12-01
- Primary completion
- 2025-01-23
- Completion
- 2025-09-17
- First posted
- 2022-11-04
- Last updated
- 2026-01-15
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05606120. Inclusion in this directory is not an endorsement.